Demande de produit
Asset Licensing Opportunity
Resources
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| Ofranergene obadenovec | VB-111; GT-111 | Phase 3 Clinical | Vascular Pharmaceuticals Inc | Ovarian Neoplasms; Thyroid Carcinoma, Anaplastic; Neoplasms; Glioblastoma; Neuroendocrine Tumors; Colorectal Neoplasms | Details |
| Atrosab | Phase 1 Clinical | Celonic | Inflammation | Details |
Customer Reviews